Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies

被引:22
|
作者
Evenden, D.
Harper, P. R. [1 ]
Brailsford, S. C.
Harindra, V.
机构
[1] Univ Southampton, Sch Med, Southampton SO17 1BJ, Hants, England
[2] Univ Southampton, Sch Management, Southampton SO17 1BJ, Hants, England
[3] St Marys Hosp, Portsmouth PO3 6AQ, Hants, England
关键词
healthcare; Chlamydia; system dynamics; geomapping; risk grouping;
D O I
10.1057/palgrave.jors.2602134
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
Chlamydia is the most common sexually transmitted infection in the UK and constitutes a major public health problem. The UK Department of Health is phasing in a National Chlamydia Screening Programme (NCSP) but there is concern that blanket screening of the entire at risk population will simply add extra burden to the already overstretched health economy. This paper demonstrates that certain high- risk sub-groups within the general population are critical in the infection dynamics. Improved targeting of these high- risk populations achieves greater cost-effectiveness. Statistical risk- group clustering techniques have been used to identify indicators that are strong predictors in determining high- risk status while geomapping techniques visually display prevalence geographically across the region, thus identifying high prevalence postcode clusters and informing public health planners where to target intervention and screening strategies. A System Dynamics simulation model has been used to capture the infection dynamics and measure the cost-effectiveness of the intervention strategies. The model incorporates risk- group behaviour as identified by the above geomapping and statistical analysis components of the research. The combined use of computer simulation, statistical analysis and geomapping methodologies has provided a unique holistic view of the problem.
引用
收藏
页码:1400 / 1412
页数:13
相关论文
共 50 条
  • [41] Cost-effectiveness of mammography screening
    Black, WC
    Tosteson, ANA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02): : 111 - 111
  • [42] Cost-effectiveness of Chlamydial screening
    Howell, MR
    Gaydos, CA
    Quinn, TC
    SEXUALLY TRANSMITTED DISEASES, 1998, 25 (08) : 406 - 407
  • [43] COST-EFFECTIVENESS OF LEAD SCREENING
    BERWICK, DM
    KOMAROFF, AL
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (23): : 1392 - 1398
  • [44] The cost-effectiveness of cancer screening
    De Koning, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S20 - S21
  • [45] Cost-effectiveness of screening for amblyopia
    Neubauer, AS
    Neubauer, S
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (02) : 110 - 116
  • [46] COST-EFFECTIVENESS OF LEAD SCREENING
    GOLDBERG, D
    DAVIDOW, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (20): : 1268 - 1268
  • [47] COST-EFFECTIVENESS OF LEAD SCREENING
    BERWICK, DM
    KOMAROFF, AL
    SHERMAN, H
    CLINICAL RESEARCH, 1980, 28 (03): : A632 - A632
  • [48] Mammography screening before the age of 50 in The Netherlands: Cost-effectiveness of different screening strategies
    Sankatsing, V. D. V.
    Heijnsdijk, E. A. M.
    van Luijt, P. A.
    van Ravesteyn, N. T.
    Fracheboud, J.
    de Koning, H. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S72 - S72
  • [49] Screening for gestational diabetes mellitus - A decision and cost-effectiveness analysis of four screening strategies
    Nicholson, WK
    Fleisher, LA
    Fox, HE
    Powe, NR
    DIABETES CARE, 2005, 28 (06) : 1482 - 1484
  • [50] Cost-effectiveness of colorectal cancer screening strategies: A systematic review
    Gheysariyeha, Fatemeh
    Rahimi, Farimah
    Tabesh, Elham
    Hemami, Mohsen Rezaei
    Adibi, Payman
    Rezayatmand, Reza
    EUROPEAN JOURNAL OF CANCER CARE, 2022, 31 (06)